Abstract
Background Incidence of morbid obesity is rising worldwide. Current clinical practice guidelines for the pre-transplant evaluation of end-stage kidney disease (ESKD) patients lack clear recommendations on morbid obesity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have